Investors Support Phage Therapy: Novel Approach to Solve the Antibiotics Crisis Receives Further Millions

Vienna (Austria), 27 June 2019: Austrian biotech company PhagoMed Biopharma GmbH successfully completed another financing round. PhagoMed, located at the Vienna Biocenter, is focused on developing virus-(phage-) based therapies against […]